UOI MSO, LLC – Trademark Portfolio
Entity Type: 16
UOI MSO, LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include UROPOINT, UROPRIME, UROLOGY OF INDIANA, and UROPRIME SELF-START THERAPY UROLOGY OF INDIANA. The owner is based in GAHANNA, OH.
701 TECH CENTER DRIVE
GAHANNA, OH 43230
Showing of trademarks Trademarks
Trademark Classifications
UOI MSO, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does UOI MSO, LLC have?
UOI MSO, LLC has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.
What trademark classes does UOI MSO, LLC file in?
UOI MSO, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are UOI MSO, LLC's most well-known trademarks?
UOI MSO, LLC's registered trademark portfolio includes well-known marks such as UROPOINT, UROPRIME, UROLOGY OF INDIANA, and UROPRIME SELF-START THERAPY UROLOGY OF INDIANA. These are among 5 currently registered trademarks in the portfolio.
What is UOI MSO, LLC's trademark registration success rate?
UOI MSO, LLC has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.